Thomas Kolter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Kolter has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Peter Sawatzki
Kekulé-Institut für Organische Chemie und Biochemie, Universität Bonn, Gerhard-Domagk Strasse 1, 53121 Bonn, Germany
7 shared publications- Martin Nieger
University of Helsinki
6 shared publications - Thomas Mikeska
Molecular Pathology Research & Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, Victoria 8006, Australia
6 shared publications Konrad Sandhoff
Life & Medical Sciences, Membrane Biology and Lipid Biochemistry Unit, Kekulé-Institut für Organische Chemie und Biochemie, Universität Bonn, D-53115 Bonn, Germany
5 shared publicationsHeike Hupfer
Kekulé-Institut für Organische Chemie und Biochemie, Universität Bonn, Gerhard-Domagk Straße 1, 53121 Bonn, Germany, Fax: (+49) 228-73-77-78
3 shared publicationsMichaela Wendeler
Kekulé-Institut für Organische Chemie und Biochemie, Universität Bonn, Gerhard-Domagk Strasse 1, 53121 Bonn, Germany
3 shared publications
Latest Publications
- 14 February 2019
- Published by Springer Nature
- p. 1-8
Lipidomics
- 2 August 2018
- Published by Springer Nature
- p. 1-10
Sphingolipids and Gangliosides
- Open Access
- 1 December 2014
- Published by Elsevier in Journal of Lipid Research
- Vol. 55 (12) , 2692-2706
Partial synthesis of ganglioside and lysoganglioside lipoforms as internal standards for MS quantification
- 1 December 2014
- Published by Elsevier in Journal of Lipid Research
- Vol. 55 (12) , 2692-2706
Open AccessPartial synthesis of ganglioside and lysoganglioside lipoforms as internal standards for MS quantification
- 1 January 2013
- Published by Springer Nature
- p. 2419-2427
Sphingolipids and Gangliosides
- 1 January 2013
- Published by Springer Nature
- p. 1296-1302
Lipidomics
- Open Access
- 19 December 2012
- Published by Wiley in ISRN Biochemistry
- Vol. 2012, 1-36
Ganglioside Biochemistry
Gangliosides are sialic acid-containing glycosphingolipids. They occur especially on the cellular surfaces of neuronal cells, where they form a complex pattern, but are also found in many other cell types. The paper provides a general overview on their structures, occurrence, and metabolism. Key functional, biochemical, and pathobiochemical aspects are summarized.
- 19 December 2012
- Published by Wiley in ISRN Biochemistry
- Vol. 2012, 1-36
Open AccessGanglioside Biochemistry
Gangliosides are sialic acid-containing glycosphingolipids. They occur especially on the cellular surfaces of neuronal cells, where they form a complex pattern, but are also found in many other cell types. The paper provides a general overview on their structures, occurrence, and metabolism. Key functional, biochemical, and pathobiochemical aspects are summarized.
- Open Access
- 2 February 2012
- Published by MDPI AG in Metabolites
- Vol. 2 (1) , 134-164
Lipidomics of Glycosphingolipids
Glycosphingolipids (GSLs) contain one or more sugars that are attached to a sphingolipid moiety, usually to a ceramide, but in rare cases also to a sphingoid base. A large structural heterogeneity results from differences in number, identity, linkage, and anomeric configuration of the carbohydrate residues, and also from structural differences within the hydrophobic part. GSLs form complex cell-type specific patterns, which change with the species, the cellular differentiation state, viral transformation, ontogenesis, and oncogenesis. Although GSL structures can be assigned to only a few series with a common carbohydrate core, their structural variety and the complex pattern are challenges for their elucidation and quantification by mass spectrometric techniques. We present a general overview of the application of lipidomics for GSL determination. This includes analytical procedures and instrumentation together with recent correlations of GSL molecular species with human diseases. Difficulties such as the structural complexity and the lack of standard substances for complex GSLs are discussed.
- 2 February 2012
- Published by MDPI AG in Metabolites
- Vol. 2 (1) , 134-164
Open AccessLipidomics of Glycosphingolipids
Glycosphingolipids (GSLs) contain one or more sugars that are attached to a sphingolipid moiety, usually to a ceramide, but in rare cases also to a sphingoid base. A large structural heterogeneity results from differences in number, identity, linkage, and anomeric configuration of the carbohydrate residues, and also from structural differences within the hydrophobic part. GSLs form complex cell-type specific patterns, which change with the species, the cellular differentiation state, viral transformation, ontogenesis, and oncogenesis. Although GSL structures can be assigned to only a few series with a common carbohydrate core, their structural variety and the complex pattern are challenges for their elucidation and quantification by mass spectrometric techniques. We present a general overview of the application of lipidomics for GSL determination. This includes analytical procedures and instrumentation together with recent correlations of GSL molecular species with human diseases. Difficulties such as the structural complexity and the lack of standard substances for complex GSLs are discussed.
- 1 January 2012
- Published by Elsevier
- p. 169-196
Glycosphingolipids
- 1 September 2011
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 164 (6) , 590-606
A view on sphingolipids and disease
- 1 September 2011
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 164 (6) , 590-606
A view on sphingolipids and disease
- Open Access
- 5 December 2010
- Published by Wiley in Journal of Lipids
- Vol. 2011, 1-9
Dihydroceramide Desaturase Inhibition by a Cyclopropanated Dihydroceramide Analog in Cultured Keratinocytes
Most mammalian sphingolipids contain a 4,5-(E)-double bond. We report on the chemical synthesis of a dihydroceramide derivative that prevents the introduction of the double bond into sphingolipids. Minimal alteration of the parent structure by formally replacing the hydrogen atoms in the 5- and in the 6-position of the sphinganine backbone by a methylene group leads to an inhibitor of dihydroceramide desaturase in cultured cells. In the presence of 10–50 μM of compound (1), levels of biosynthetically formed dihydroceramide and—surprisingly—also of phytoceramide are elevated at the expense of ceramide. The cells respond to the lack of unsaturated sphingolipids by an elevation of mRNAs of enzymes required for sphingosine formation. At the same time, the analysis of proliferation and differentiation markers indicates that the sphingolipid double bond is required to keep the cells in a differentiated state.
- 5 December 2010
- Published by Wiley in Journal of Lipids
- Vol. 2011, 1-9
Open AccessDihydroceramide Desaturase Inhibition by a Cyclopropanated Dihydroceramide Analog in Cultured Keratinocytes
Most mammalian sphingolipids contain a 4,5-(E)-double bond. We report on the chemical synthesis of a dihydroceramide derivative that prevents the introduction of the double bond into sphingolipids. Minimal alteration of the parent structure by formally replacing the hydrogen atoms in the 5- and in the 6-position of the sphinganine backbone by a methylene group leads to an inhibitor of dihydroceramide desaturase in cultured cells. In the presence of 10–50 μM of compound (1), levels of biosynthetically formed dihydroceramide and—surprisingly—also of phytoceramide are elevated at the expense of ceramide. The cells respond to the lack of unsaturated sphingolipids by an elevation of mRNAs of enzymes required for sphingosine formation. At the same time, the analysis of proliferation and differentiation markers indicates that the sphingolipid double bond is required to keep the cells in a differentiated state.